secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0000950170-23-002241
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker Q4 non-GAAP EPS $0.74 (+25% YoY); FY23 organic growth guidance 8-10%
---------------------------------------------------------------------------

- Q4 revenues $708.4M (+3.6% reported, +8.9% organic); GAAP EPS $0.66 vs $0.50.
- FY22 revenues $2.531B (+4.7% reported, +10.2% organic); non-GAAP EPS $2.34 (+11.4%).
- FY23 guidance: revenue $2.81-2.86B (8-10% organic); non-GAAP EPS $2.52-2.57 (8-10% growth).
- BSI organic growth 9.5% (FY); BEST organic growth 17.4%; non-GAAP op margin expanded to 20.0%.
- Management cites double-digit organic bookings growth and accelerated investments in proteomics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/brkr-20230209.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-002241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer